Qilian International Holding Group Ltd (Nasdaq: QLI), a China-based pharmaceutical and chemical products manufacturer, announced on Thursday a special one-time cash dividend of USD0.05 per ordinary share.
"Despite the impacts of COVID-19 on us in our last fiscal year, the company maintained decent operating results and healthy cash flow," said Zhanchang Xin, CEO. "We expect better financial results as China announced a rollback of its anti-COVID measures."
The special dividend will be paid on or around 6 March 2023 to shareholders of record at 28 February 2023.
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
AstraZeneca increases dividend by 7%
Poolbeg PHarma plc receives notice of allowance for POLB 001 patent
Wolters Kluwer enhances Clinical GenAI leadership with AI Labs powered by UpToDate
Amgen announces share dividend for Q2 2024
Virbac expands presence in Japan with Sasaeah acquisition
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Danaher Corporation announces quarterly cash dividend
Abbott announces quarterly common dividend
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva